Middle East Medical Cannabis Market, by Derivative

Growth Outlook

• The Middle East Medical Cannabis Market, by Derivative market is on a steady long-term growth path. Segment value stands at roughly USD 37 Mn in 2026 and is projected to reach USD 45 Mn by 2027 — a gain of about 22% over the forecast period, translating to a CAGR in the double digits.
• What the regional split looks like (2026): Cannabidiol leads, holding roughly 72% of segment value — the single largest regional share. Tetrahydrocannabinol is the second-largest contributor.
• By 2027, Cannabidiol alone is expected to reach USD 33 Mn, with Tetrahydrocannabinol at USD 12 Mn.

Market Dynamics

The Middle East medical cannabis market has been gaining significant attention in recent years, with the region showing a growing interest in the potential benefits of cannabis-derived products for medicinal purposes. This demand has been met with regulatory changes and an increase in production and distribution of various cannabis derivatives, leading to a burgeoning market for these products in the region.

One of the main derivatives of medical cannabis that has seen a surge in demand in the Middle East is CBD (Cannabidiol). CBD is a non-psychoactive compound found in cannabis, and its potential therapeutic effects have been widely studied and accepted. This has led to an increase in demand for CBD-based medicines, supplements, and oils in the region. CBD is known for its anti-inflammatory, analgesic, and anti-anxiety properties, making it a popular choice for patients suffering from chronic pain, multiple sclerosis, and anxiety disorders.

Another derivative that has seen a rise in demand is THC (Tetrahydrocannabinol). Unlike CBD, THC is a psychoactive compound that is responsible for the "high" associated with cannabis. While recreational use of THC is still not legal in most Middle Eastern countries, its medical benefits are slowly gaining recognition. THC-based medicines have been found to be effective in relieving symptoms of conditions such as chemotherapy-induced nausea, glaucoma, and anorexia.

Additionally, other derivatives of cannabis such as terpenes, flavonoids, and cannabinoids have also seen a growing demand in the region. These compounds are believed to work together to produce the "entourage effect", amplifying the potential therapeutic benefits of cannabis. Terpenes and flavonoids are known for their anti-inflammatory, antioxidant, and analgesic properties, while cannabinoids such as CBG (Cannabigerol) and CBDA (Cannabidiolic acid) have shown potential in treating conditions such as epilepsy and inflammatory bowel disease.

The Middle East's demand for medical cannabis derivatives can also be attributed to the growing awareness and acceptance of alternative and natural forms of medicine. With a long history of using plants and herbs for medicinal purposes, the region is open to exploring the potential benefits of cannabis derivatives as an alternative to traditional pharmaceuticals.

In conclusion, the demand for medical cannabis derivatives in the Middle East is on the rise, fueled by a growing interest in natural and alternative forms of medicine. With an increasing range of products and derivatives available in the market, the region is set to witness a significant growth in the use of medical cannabis for therapeutic purposes.